Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/1999
11/16/1999US5985880 Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
11/16/1999US5985877 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer
11/16/1999US5985873 Useful in the diagnosis and treatment of feeding disorders such as obesity and bulimia and cardiovascular diseases such as essential hypertension and congestive heart failure due to the binding of these compounds to human neuropeptide y1
11/16/1999US5985872 2-amino-benzoxazinones for the treatment of viral infections
11/16/1999US5985871 Benzoxazine compounds for enhancing synaptic response
11/16/1999US5985866 Use of serotonin antagonists for treating fibromyalgia
11/16/1999US5985859 Methods of inhibiting bacterial sialidase
11/16/1999US5985857 Generating stable protein-sugar post-amadori advanced glycation end-product (age) intermediates comprising incubating protein with pentose sugar
11/16/1999US5985854 Prodrugs with enhanced penetration into cells
11/16/1999US5985852 Composition for inhibiting binding between a first cell having a p- or l-selectin and a second cell having a ligand for the selectin, comprising a sheet of lipids
11/16/1999US5985849 Phosphate compounds and their use as medicaments
11/16/1999US5985848 Inhibitors of nucleoside metabolism
11/16/1999US5985841 Deoxyglucopyranoside compounds for inducing/stimulating hair growth and/or retarding hair loss
11/16/1999US5985657 Nucleotide sequence coding for human il-1; expression vectors and host cells
11/16/1999US5985640 Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same
11/16/1999US5985589 Dna sequences
11/16/1999US5985335 Potassium citrate, malate or lactate; vitamin d, calcium salt and vitamin k; bone disorders, osteoporosis treatment; foods; dietetics
11/16/1999US5985334 Contacting test compound to receptor from rat brain tissue that binds 6-acetyl-4-benzamido-3-hydroxy-2,2-dimethylbenzopyran derivatives
11/16/1999US5985279 Humanized antibody against CD18
11/16/1999CA2088761C Benzimidazole derivatives, process for their preparation and application
11/16/1999CA2064815C Therapeutic heterocyclic compounds
11/16/1999CA2031746C Formulated medicines for enhancing the efficacy of beta-lactam antibiotics in prophylaxis and treatment against infectious disease due to pathogenic bacteria
11/16/1999CA2002864C (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
11/14/1999CA2270022A1 Combination of dofetilide and a calcium channel blocker
11/11/1999WO1999057320A1 Antisense modulation of cd40 expression
11/11/1999WO1999057303A1 A method for diagnosing and treating chronic pelvic pain syndrome
11/11/1999WO1999057295A1 Recombinant virus expressing foreign dna encoding feline cd80, feline ctla-4 or feline cd86 and uses thereof
11/11/1999WO1999057291A1 Genomic sequences upstream of the coding region of the g-csf gene for protein production and delivery
11/11/1999WO1999057290A1 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
11/11/1999WO1999057288A1 Endothelin-converting-enzyme like protein
11/11/1999WO1999057283A1 Preparation of human papillomavirus e1 having helicase activity and method therefor
11/11/1999WO1999057271A2 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides
11/11/1999WO1999057270A2 Human receptor molecules
11/11/1999WO1999057266A2 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction)
11/11/1999WO1999057261A2 Human bmp-2 promoter and method for exploring bone-related substance by using the same
11/11/1999WO1999057251A2 Thrombolytic agents derived from streptokinase
11/11/1999WO1999057241A2 Myelin basic protein peptides and uses thereof
11/11/1999WO1999057152A1 Oral administration of immunoglobulins for treating autoimmune hearing loss
11/11/1999WO1999057149A2 Compounds and methods for modulating nonclassical cadherin-mediated functions
11/11/1999WO1999057148A1 Melanocortin 1 receptor selective compounds
11/11/1999WO1999057146A1 Protein mixtures to induce therapeutic angiogenesis
11/11/1999WO1999057144A2 Human transcriptional regulator molecules
11/11/1999WO1999057140A2 Growth-associated protease inhibitor heavy chain precursor
11/11/1999WO1999057139A2 Pth2 receptor selective compounds
11/11/1999WO1999057133A2 Inhibitors of nf-kb activation
11/11/1999WO1999057115A1 Novel benzimidazoles and benzoxazoles
11/11/1999WO1999057114A1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
11/11/1999WO1999057113A1 Heterocyclic derivatives which inhibit factor xa
11/11/1999WO1999057112A1 Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl] piperazine
11/11/1999WO1999057102A1 Substituted sulphonyl cyanamides, method for producing same and their use as medicament
11/11/1999WO1999057101A1 Pyrazole derivatives as p-38 map kinase inhibitors
11/11/1999WO1999057100A1 Spla2 inhibitor compounds for treatment of disease
11/11/1999WO1999057099A1 Heterocyclic derivatives which inhibit factor xa
11/11/1999WO1999057096A1 Biphenyl derivatives
11/11/1999WO1999056784A2 Inprovements in gene therapy using compositions comprising a polynucleotide and a nuclease inhibitor or interleukin-10
11/11/1999WO1999056783A1 Hydrogel for the therapeutic treatment of aneurysms
11/11/1999WO1999056781A1 Methods of using isomer enriched conjugated linoleic acid compositions
11/11/1999WO1999056780A1 Isomer enriched conjugated linoleic acid compositions
11/11/1999WO1999056771A2 Methods of raising animals for meat production
11/11/1999WO1999056769A2 Inhibition of helicobacter pylori proliferation
11/11/1999WO1999056768A1 Methods for treating diabetes by inhibiting gdf-8
11/11/1999WO1999056767A2 Method for treating cytokine mediated hepatic injury
11/11/1999WO1999056766A2 Method for treating ischemia
11/11/1999WO1999056765A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
11/11/1999WO1999056763A1 Use of neglected target tissue antigens in modulation of immune responses
11/11/1999WO1999056759A1 Bone marrow cells as a source of neurons for brain and spinal cord repair
11/11/1999WO1999056753A1 Hematopoietic stimulation
11/11/1999WO1999056752A1 sPLA2 INHIBITOR ESTER
11/11/1999WO1999056750A1 Use of 4-piperidinemethanol derivatives in treatment of neurodevelopmental disorders
11/11/1999WO1999056746A1 Hydroxyomeprazole compositions and uses
11/11/1999WO1999056740A1 Assay for identification of compounds that promote melanin production and retinoid-like compounds identified by said assay
11/11/1999WO1999056737A1 Arylhydrocarbon receptor ligand antagonists
11/11/1999WO1999056734A2 Transdermal therapeutic system for the administration of candesartan
11/11/1999WO1999056723A2 Hemoglobine-haptoglobin complexes for targeted drug delivery
11/11/1999WO1999049316A3 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer
11/11/1999WO1999047132A3 Heterocyclic compounds, their production and use as tachykinin receptor antagonists
11/11/1999WO1999046240A3 Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors
11/11/1999WO1999045916A3 Novel methods for treating disorders in which docosahexaenoic acid (dha) levels are affected
11/11/1999WO1999045016A9 Novel prodrugs for phosphorus-containing compounds
11/11/1999WO1999044988A3 Method for preparing sulfanyl-type endothelin receptor antagonists
11/11/1999WO1999043791A9 Diisopropyl fluorophosphatase and the utilization and production thereof
11/11/1999WO1999040083A3 Bifunctional tryptase inhibitors
11/11/1999WO1999040073A3 Tryptase inhibitors
11/11/1999DE19820151A1 Transdermales therapeutisches System zur Anwendung von Candesartan Transdermal therapeutic system for application of candesartan
11/11/1999DE19820064A1 Substituierte Sulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituted Sulfonylcyanamide, processes for their preparation and their use as a medicament
11/11/1999CA2331863A1 Substituted sulphonyl cyanamides, method for producing same and their use as medicament
11/11/1999CA2331844A1 A method for diagnosing and treating chronic pelvic pain syndrome
11/11/1999CA2331738A1 Oral administration of immunoglobulins for treating autoimmune hearing loss
11/11/1999CA2331364A1 Arylhydrocarbon receptor ligand antagonists
11/11/1999CA2331122A1 Hematopoietic stimulation
11/11/1999CA2331042A1 Heterocyclic derivatives which inhibit factor xa
11/11/1999CA2331041A1 Reduced particle size form of 1-(6-chloronaphth-2-ylsulphonyl)-4-¬4-(4pyridyl)benzoyl|piperazine
11/11/1999CA2331037A1 Novel benzimidazoles and benzoxazoles
11/11/1999CA2331036A1 Spla2 inhibitor ester
11/11/1999CA2330856A1 Spla2 inhibitor compounds for treatment of disease
11/11/1999CA2330665A1 Protein mixtures to induce therapeutic angiogenesis
11/11/1999CA2330568A1 Use of 4-piperidinemethanol derivatives in treatment of neurodevelopmental disorders
11/11/1999CA2330049A1 Hydroxyomeprazole compositions and uses
11/11/1999CA2329065A1 Pyrazole derivatives as p-38 map kinase inhibitors
11/11/1999CA2328732A1 Biphenyl derivatives
1 ... 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 ... 1564